Clinical application of non-invasive prenatal testing using cell free fetal DNA
Journal of the Korean Medical Association
;
: 771-779, 2014.
Artigo
em Coreano
| WPRIM
| ID: wpr-51688
ABSTRACT
Non-invasive prenatal testing using next generation sequencing technology with cell free fetal DNA from the blood of pregnant women has been rapidly adopted as a screening test for the detection of disorders involving chromosomal aneuploidy, especially Down syndrome. However as part of a prenatal recommendation in high-risk group, this laboratory assessment should be accompanied by informed counseling at both pre-test and post-test stages. In low-risk group and multifetal pregnancies, only conventional maternal serum screening tests in the first trimester and/or second trimester in addition to measurement of nuchal translucency should be recommended, until this potential tool has been incorporated into current screening strategic modalities on the basis ofsufficient published data.
Texto completo:
DisponíveL
Índice:
WPRIM (Pacífico Ocidental)
Assunto principal:
Segundo Trimestre da Gravidez
/
Primeiro Trimestre da Gravidez
/
DNA
/
Programas de Rastreamento
/
Síndrome de Down
/
Aconselhamento
/
Gestantes
/
Medição da Translucência Nucal
/
Testes para Triagem do Soro Materno
/
Aneuploidia
Tipo de estudo:
Estudo de rastreamento
Limite:
Feminino
/
Humanos
/
Gravidez
Idioma:
Coreano
Revista:
Journal of the Korean Medical Association
Ano de publicação:
2014
Tipo de documento:
Artigo
Similares
MEDLINE
...
LILACS
LIS